Get the Stockscreener App
31.05
2.11%
-0.68
Sanara Medtech Inc stock is traded at $31.05, with a volume of 23,795.
It is down -2.11% in the last 24 hours and down -7.72% over the past month.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
See More
Previous Close:
$31.73
Open:
$31.45
24h Volume:
23,795
Relative Volume:
0.60
Market Cap:
$280.74M
Revenue:
$64.99M
Net Income/Loss:
$-4.30M
P/E Ratio:
-59.71
EPS:
-0.52
Net Cash Flow:
$-3.51M
1W Performance:
-4.64%
1M Performance:
-7.72%
6M Performance:
+2.27%
1Y Performance:
+7.10%
1-Day Range:
$30.36
$31.99
1-Week Range:
$30.36
$33.33
52-Week Range:
$23.53
$39.08
Sanara Medtech Inc Stock (SMTI) Company Profile
Name
Sanara Medtech Inc
Sector
Industry
Phone
817-529-2300
Address
1200 SUMMIT AVE, FORT WORTH
Compare SMTI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
31.54 | 282.47M | 64.99M | -4.30M | -3.51M | -0.52 |
|
ISRG
Intuitive Surgical Inc
|
434.61 | 160.32B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
190.48 | 53.65B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
269.57 | 40.08B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
74.51 | 36.84B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
270.77 | 18.86B | 2.96B | 487.70M | 344.00M | 6.68 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-26-25 | Reiterated | H.C. Wainwright | Buy |
| Dec-23-24 | Initiated | H.C. Wainwright | Buy |
| May-20-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-30-21 | Initiated | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc Stock (SMTI) Latest News
Sanara MedTech to Report Third Quarter 2025 Financial Results on November 12, 2025 - GlobeNewswire
Medical Tech Company Sanara MedTech Announces Q3 2025 Results Schedule and Conference Call Details - Stock Titan
Is Sanara MedTech Inc. forming a reversal patternPortfolio Performance Summary & Stepwise Swing Trade Plans - newser.com
Trend analysis for Sanara MedTech Inc. this weekNew Guidance & Low Risk Entry Point Tips - newser.com
Can momentum traders help lift Sanara MedTech Inc.Market Growth Report & Safe Capital Growth Tips - newser.com
Multi factor analysis applied to Sanara MedTech Inc.Market Weekly Review & Low Risk Growth Stock Ideas - newser.com
Why Sanara MedTech Inc. stock remains undervaluedStock Surge & Community Consensus Stock Picks - newser.com
What the charts say about Sanara MedTech Inc. todayWeekly Trend Recap & AI Powered Trade Plan Recommendations - newser.com
What analysts say about Sanara MedTech Inc stockGeopolitical Risk Analysis & Hedge Fund-Style Analysis Now Free - earlytimes.in
Is Sanara MedTech Inc. stock overvalued by current metricsTrade Entry Summary & High Conviction Buy Zone Picks - newser.com
Evaluating Sanara MedTech Inc. with trendline analysisJuly 2025 Setups & Verified Swing Trading Watchlists - newser.com
Goldman Sachs Group Inc. Trims Stock Holdings in Sanara MedTech Inc. $SMTI - Defense World
Sanara MedTech Inc Stock Analysis and ForecastVolume Weighted Average Price & Receive Monthly Expert Trading Blueprints - Early Times
Top Growth Companies With Insider Stakes In September 2025 - simplywall.st
Can Sanara MedTech Inc. deliver consistent dividendsProduct Launch & Weekly Stock Breakout Alerts - baoquankhu1.vn
Technical analysis overview for Sanara MedTech Inc. stockJuly 2025 Analyst Calls & Proven Capital Preservation Methods - newser.com
What moving averages say about Sanara MedTech Inc.Bull Run & Consistent Return Strategy Ideas - newser.com
Sanara MedTech targets pilot launch of Tissue Health Plus in Q2 2025 - MSN
Jobs Data: Can Sanara MedTech Inc maintain sales growthQuarterly Profit Review & Momentum Based Trading Ideas - khodrobank.com
Sanara Medtech Inc Stock (SMTI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.61%
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):